BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 28523591)

  • 1. Assessment of the Neuroprotective Effects of Arginine-Rich Protamine Peptides, Poly-Arginine Peptides (R12-Cyclic, R22) and Arginine-Tryptophan-Containing Peptides Following In Vitro Excitotoxicity and/or Permanent Middle Cerebral Artery Occlusion in Rats.
    Meloni BP; Milani D; Cross JL; Clark VW; Edwards AB; Anderton RS; Blacker DJ; Knuckey NW
    Neuromolecular Med; 2017 Sep; 19(2-3):271-285. PubMed ID: 28523591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of neuroprotective efficacy of poly-arginine R18 and R18D (D-enantiomer) peptides following permanent middle cerebral artery occlusion in the Wistar rat and in vitro toxicity studies.
    Milani D; Bakeberg MC; Cross JL; Clark VW; Anderton RS; Blacker DJ; Knuckey NW; Meloni BP
    PLoS One; 2018; 13(3):e0193884. PubMed ID: 29513757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Poly-arginine peptides reduce infarct volume in a permanent middle cerebral artery rat stroke model.
    Milani D; Clark VW; Cross JL; Anderton RS; Knuckey NW; Meloni BP
    BMC Neurosci; 2016 May; 17(1):19. PubMed ID: 27142074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative Assessment of the Proteolytic Stability and Impact of Poly-Arginine Peptides R18 and R18D on Infarct Growth and Penumbral Tissue Preservation Following Middle Cerebral Artery Occlusion in the Sprague Dawley Rat.
    Milani D; Clark VW; Feindel KW; Blacker DJ; Bynevelt M; Edwards AB; Anderton RS; Knuckey NW; Meloni BP
    Neurochem Res; 2021 May; 46(5):1166-1176. PubMed ID: 33523394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterisation of neuroprotective efficacy of modified poly-arginine-9 (R9) peptides using a neuronal glutamic acid excitotoxicity model.
    Edwards AB; Anderton RS; Knuckey NW; Meloni BP
    Mol Cell Biochem; 2017 Feb; 426(1-2):75-85. PubMed ID: 27844251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Neuroprotective Peptide Poly-Arginine-12 (R12) Reduces Cell Surface Levels of NMDA NR2B Receptor Subunit in Cortical Neurons; Investigation into the Involvement of Endocytic Mechanisms.
    MacDougall G; Anderton RS; Edwards AB; Knuckey NW; Meloni BP
    J Mol Neurosci; 2017 Feb; 61(2):235-246. PubMed ID: 27866326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Poly-arginine and arginine-rich peptides are neuroprotective in stroke models.
    Meloni BP; Brookes LM; Clark VW; Cross JL; Edwards AB; Anderton RS; Hopkins RM; Hoffmann K; Knuckey NW
    J Cereb Blood Flow Metab; 2015 Jun; 35(6):993-1004. PubMed ID: 25669902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro cellular uptake and neuroprotective efficacy of poly-arginine-18 (R18) and poly-ornithine-18 (O18) peptides: critical role of arginine guanidinium head groups for neuroprotection.
    MacDougall G; Anderton RS; Ouliel E; Gao J; Redmond SL; Knuckey NW; Meloni BP
    Mol Cell Biochem; 2020 Jan; 464(1-2):27-38. PubMed ID: 31679100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroprotective peptides fused to arginine-rich cell penetrating peptides: Neuroprotective mechanism likely mediated by peptide endocytic properties.
    Meloni BP; Milani D; Edwards AB; Anderton RS; O'Hare Doig RL; Fitzgerald M; Palmer TN; Knuckey NW
    Pharmacol Ther; 2015 Sep; 153():36-54. PubMed ID: 26048328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Poly-arginine R18 and R18D (D-enantiomer) peptides reduce infarct volume and improves behavioural outcomes following perinatal hypoxic-ischaemic encephalopathy in the P7 rat.
    Edwards AB; Cross JL; Anderton RS; Knuckey NW; Meloni BP
    Mol Brain; 2018 Feb; 11(1):8. PubMed ID: 29426351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delayed 2-h post-stroke administration of R18 and NA-1 (TAT-NR2B9c) peptides after permanent and/or transient middle cerebral artery occlusion in the rat.
    Milani D; Cross JL; Anderton RS; Blacker DJ; Knuckey NW; Meloni BP
    Brain Res Bull; 2017 Oct; 135():62-68. PubMed ID: 28964774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroprotective efficacy of poly-arginine R18 and NA-1 (TAT-NR2B9c) peptides following transient middle cerebral artery occlusion in the rat.
    Milani D; Cross JL; Anderton RS; Blacker DJ; Knuckey NW; Meloni BP
    Neurosci Res; 2017 Jan; 114():9-15. PubMed ID: 27639457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteomic analysis of cortical neuronal cultures treated with poly-arginine peptide-18 (R18) and exposed to glutamic acid excitotoxicity.
    MacDougall G; Anderton RS; Mastaglia FL; Knuckey NW; Meloni BP
    Mol Brain; 2019 Jul; 12(1):66. PubMed ID: 31315638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploring the role of MKK7 in excitotoxicity and cerebral ischemia: a novel pharmacological strategy against brain injury.
    Vercelli A; Biggi S; Sclip A; Repetto IE; Cimini S; Falleroni F; Tomasi S; Monti R; Tonna N; Morelli F; Grande V; Stravalaci M; Biasini E; Marin O; Bianco F; di Marino D; Borsello T
    Cell Death Dis; 2015 Aug; 6(8):e1854. PubMed ID: 26270349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Poly-arginine-18 (R18) Confers Neuroprotection through Glutamate Receptor Modulation, Intracellular Calcium Reduction, and Preservation of Mitochondrial Function.
    MacDougall G; Anderton RS; Trimble A; Mastaglia FL; Knuckey NW; Meloni BP
    Molecules; 2020 Jun; 25(13):. PubMed ID: 32610439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The neuroprotective efficacy of cell-penetrating peptides TAT, penetratin, Arg-9, and Pep-1 in glutamic acid, kainic acid, and in vitro ischemia injury models using primary cortical neuronal cultures.
    Meloni BP; Craig AJ; Milech N; Hopkins RM; Watt PM; Knuckey NW
    Cell Mol Neurobiol; 2014 Mar; 34(2):173-81. PubMed ID: 24213248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of R18, COG1410, and APP96-110 in Excitotoxicity and Traumatic Brain Injury.
    Chiu LS; Anderton RS; Cross JL; Clark VW; Edwards AB; Knuckey NW; Meloni BP
    Transl Neurosci; 2017; 8():147-157. PubMed ID: 29177102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GIF-0173 protects against cerebral infarction through DP1 receptor activation.
    Thura M; Hokamura K; Yamamoto S; Maeda M; Furuta K; Suzuki M; Ibaraki K; Umemura K
    Exp Neurol; 2009 Oct; 219(2):481-91. PubMed ID: 19576888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroprotective effect of a novel Chinese herbal decoction on cultured neurons and cerebral ischemic rats.
    Ip FC; Zhao YM; Chan KW; Cheng EY; Tong EP; Chandrashekar O; Fu GM; Zhao ZZ; Ip NY
    BMC Complement Altern Med; 2016 Nov; 16(1):437. PubMed ID: 27814708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurotrophic and neuroprotective effects of oxyntomodulin in neuronal cells and a rat model of stroke.
    Li Y; Wu KJ; Yu SJ; Tamargo IA; Wang Y; Greig NH
    Exp Neurol; 2017 Feb; 288():104-113. PubMed ID: 27856285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.